You may be eligible to participate in a new research study to test whether a novel investigational medication improves cognition and thinking.
The study involves 7 in-person visits, including an initial intake visit, 5 MRI visits, and 1 follow up visit, as well as a brief phone check in 1 month after completion of the study. An investigational medication is taken prior to the scan on each of the 5 MRI visits. In addition to medical assessments, participants will complete clinical interviews, cognitive assessments, MRIs and collection of blood samples.
Total compensation is up to $2,910.
Fill out survey at https://redcap.med.upenn.edu/surveys/?s=EMJ73KN7KC9PXJ44 or https://clinicalresearch.itmat.upenn.edu/clinicaltrial/6697/a-translational-and-neurocomputational-evaluation-of-a-d1r-partial-agonist-for-schizophrenia to indicate interest.
Discussion
By posting you agree to the Terms and Privacy Policy.